Analysis of multidisciplinary lung cancer practice
- 12 December 2006
- journal article
- Published by Wiley in Internal Medicine Journal
- Vol. 37 (1) , 18-25
Abstract
Background: The aim of this study was to describe the activity of a lung cancer multidisciplinary clinic (MDC) and examine whether this model of clinical practice results in adherence to best‐practice guidelines.Methods: Prospective analysis of demographic and clinical data in 431 patients referred to a lung cancer MDC for the management of known or suspected thoracic malignancy. Adherence was documented to clinically relevant guideline recommendations concerning timely and evidence‐based lung cancer management.Results: Of 431 patients, 257 were diagnosed with primary lung cancer, mean age 68 years, 70% men and 90% current smokers or ex‐smokers. Only 21% were referred with known malignancy and 28% were asymptomatic. Overall, 51% had stages I and II non‐small‐cell lung cancer, with this bias towards early‐stage disease greatest in patients from rural areas. Histological confirmation of lung cancer was obtained in 92%. There was a high rate of adherence to international guideline recommendations concerning timely lung cancer diagnosis, staging and treatment implementation. Similarly, there was adherence to selected key evidence based recommendations for lung cancer management contained in national guidelines.Conclusion: Within a MDC, patients receive timely diagnosis, staging and treatment according to evidence‐based guideline recommendations. The high proportion of patients receiving active treatment has implications for resource allocation. There is a referral bias towards patients with early non‐small‐cell lung cancer, particularly in rural patients, suggesting that further education about advances in metastatic lung cancer management is required. This study would support the establishment of regional lung cancer services with links to fully resourced MDC.Keywords
This publication has 22 references indexed in Scilit:
- Treatment of Advanced Non–Small-Cell Lung Cancer in the Elderly: Results of an International Expert PanelJournal of Clinical Oncology, 2005
- A Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the LungNew England Journal of Medicine, 2004
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003Journal of Clinical Oncology, 2004
- Lung cancer patterns of care in south western Sydney, AustraliaThorax, 2003
- Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapyLung Cancer, 1999
- Delays in the diagnosis and surgical treatment of lung cancer.Thorax, 1996
- Benefits from specialised cancer careThe Lancet, 1996
- Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancerAnnals of Oncology, 1994
- Patients presenting with lung cancer in south east Scotland. Edinburgh Lung Cancer Group.Thorax, 1987